Log in to save to my catalogue

Bruton’s Tyrosine Kinase Inhibition in Multiple Sclerosis

Bruton’s Tyrosine Kinase Inhibition in Multiple Sclerosis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2731632733

Bruton’s Tyrosine Kinase Inhibition in Multiple Sclerosis

About this item

Full title

Bruton’s Tyrosine Kinase Inhibition in Multiple Sclerosis

Author / Creator

Publisher

New York: Springer US

Journal title

Current neurology and neuroscience reports, 2022-11, Vol.22 (11), p.721-734

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Purpose of Review
Multiple sclerosis (MS) is an inflammatory disease of the central nervous system (CNS) with a chronic and often progressive disease course. The current disease-modifying treatments (DMTs) limit disease progression primarily by dampening immune cell activity in the peripheral blood or hindering their migration from the periphery...

Alternative Titles

Full title

Bruton’s Tyrosine Kinase Inhibition in Multiple Sclerosis

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2731632733

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2731632733

Other Identifiers

ISSN

1528-4042

E-ISSN

1534-6293

DOI

10.1007/s11910-022-01229-z

How to access this item